A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W.
Transplantation Proceedings 19(5): 4063-4065
1987
ISSN/ISBN: 0041-1345 PMID: 2823431 Document Number: 300216
Document emailed within 1 workday
Related Documents
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897Gondo, H. 1998: Cytomegalovirus infection in transplant recipients Nihon Rinsho. Japanese Journal of Clinical Medicine 56(1): 173-178
Jankowski, M.; Gut, W.; Nawrocka, E.; Gradowska, L.; Roncewicz, Z.; Rowińska, D. 1982: Cytomegalovirus antibodies in renal transplant recipients Acta Microbiologica Polonica 31(3-4): 279-285
Metselaar, H.J.; Rothbarth, P.H.; Brouwer, R.M.; Wenting, G.J.; Jeekel, J.; Weimar, W. 1989: Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection Transplantation 48(2): 264-266
Sivathasan, C.; Doraisingham, S.; Ling, A.E.; Ng, A.; Allen, D.M.; Tong, M.C. 1992: Is cytomegalovirus infection going to be a problem among heart transplant recipients in Singapore? Transplantation Proceedings 24(5): 2019-2021
Pollard, R.B.; Merigan, T.C. 1978: Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients Transplantation Proceedings 10(1): 241-245
Mourad, G.; Chong, G.; Pouliquen, M.; Ruiz, G.; Mandin, J.; Mion, C. 1984: Withdrawal of azathioprine and antilymphocyte globulins in kidney transplant recipients with cytomegalovirus Transplantation Proceedings 16(5): 1313-1315
Lautenschlager, I.; Ahonen, J.; Eklund, B.; Höckerstedt, K.; Isoniemi, H.; Salmela, K.; Häyry, P. 1990: Detection of cytomegalovirus-specific early antigens from blood leukocytes and bronchoalveolar lavage cells in the diagnosis of active cytomegalovirus infection in transplant patients Transplantation Proceedings 22(1): 233
Lilleri, D.; Gerna, G.; Bruno, F.; Draghi, P.; Gabanti, E.; Fornara, C.; Meloni, F. 2013: Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients New Microbiologica 36(3): 267-277
Costa, C.; Sidoti, F.; Mantovani, S.; Gregori, G.; Proietti, A.; Ghisetti, V.; Cavallo, R. 2016: Comparison of two molecular assays for detection of cytomegalovirus DNA in whole blood and plasma samples from transplant recipients New Microbiologica 39(3): 186-191
Harland, R.C.; Vernon, W.B.; Bunzendahl, H.; Thompson, J.K.; Lawrence, C.; Bollinger, R.R. 1994: Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients Transplantation Proceedings 26(2): 432-433
Mutimer, D.; Mirza, D.; Shaw, J.; O'Donnell, K.; Elias, E. 1997: Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients Transplantation 63(10): 1411-1415
Reina, J.; Alberto, C.; Ballesteros, F.; Munar, M.; Marí, M. 1999: Comparison between centrifugation and sedimentation prior to cultures in the isolation of cytomegalovirus in the urine of renal transplant recipients Enfermedades Infecciosas y Microbiologia Clinica 17(2): 82-84
Baldwin, W.M.; van Es, A.; Valentijn, R.M.; van Gemert, G.W.; Daha, M.R.; Vanes, L.A. 1982: Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections Clinical and Experimental Immunology 50(3): 515-524
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Dreikorn, K.; Doerr, H.W.; Geursen, R.G. 1985: Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG Scandinavian Journal of Urology and Nephrology. Supplementum 92: 15-21
Kapoor, N.; Copelan, E.A.; Tutschka, P.J. 1989: Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent Transplantation Proceedings 21(1 Part 3): 3095-3096
Moreno, J.; Montero, J.L.; Gavilán, F.; Costán, G.; Herrero, C.; Cárdenas, M.; Sánchez-Guijo, P.; Torre-Cisneros, J. 1999: Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients Enfermedades Infecciosas y Microbiologia Clinica 17(8): 382-385
Shao, Y.L.; Shelby, J.; Hisatake, G.; Kern, E.R.; Nelson, E.W.; Gay, W.A. 1991: Accelerated cardiac allograft rejection in murine cytomegalovirus-infected C3H recipients Transplantation Proceedings 23(1 Part 1): 129-130
Siennicka, J.; Durlik, M.; Litwińska, B.; Chmura, A.; Lewandowska, D.; Lao, M.; Paczek, L.; Kańtoch, M. 1999: Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment Acta Microbiologica Polonica 48(1): 61-71